Status:
WITHDRAWN
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Actinic Cheilitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Actinic cheilitis is a condition of the lower lip characterized by grayish-white areas of discoloration and blunting of the demarcation between the cutaneous lip and the mucosa. While many studies ha...
Detailed Description
The proposed study will be a prospective cohort study of all patients with actinic cheilitis presenting to the study institution, the Queen Elizabeth II Health Science Center in Halifax, from March 1s...
Eligibility Criteria
Inclusion
- Inclusion criteria will include all patients with actinic cheilitis that do not meet exclusion criteria.
Exclusion
- Exclusion criteria will include patients younger than 18 years of age and patients with a biopsy proven malignancy of the lip.
Key Trial Info
Start Date :
September 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04744103
Start Date
September 15 2023
End Date
September 15 2023
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QEII
Halifax, Nova Scotia, Canada, B3H 2Y9